We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Genus Lifesciences has filed suit against the FDA in the U.S. District Court for the District of Columbia, alleging that the agency violated the 5-year exclusivity of a Genus product in approving a competitor’s application for a rival product. Read More
Drugmakers are ramping up efforts to develop countermeasures for the coronavirus outbreak, which the World Health Organization yesterday declared a global health emergency. Read More
Innovative cancer drugs are taking longer to get from clinical trials to EMA approval and availability for UK patients than more conventional treatments, the London-based Institute of Cancer Research (ICR) reported. Read More
A House subcommittee took up four bipartisan drug bills yesterday, including one — introduced in October — that would close a loophole in the FDA’s orphan drug program. Read More